expert roundtables

Use of Splenectomy in the Treatment of Chronic Immune Thrombocytopenia
Hematology

Use of Splenectomy in the Treatment of Chronic Immune Thrombocytopenia

expert roundtables
By Adam Cuker, MD, MS; Howard A. Liebman, MD; Terry B. Gernsheimer, MD
Biological and Clinical Predictive Factors of Response in Patients With Chronic Immune Thrombocytopenia
Hematology

Biological and Clinical Predictive Factors of Response in Patients With Chronic Immune Thrombocytopenia

expert roundtables
By Adam Cuker, MD, MS; Howard A. Liebman, MD; Terry B. Gernsheimer, MD
Choosing Between Thrombopoietin Receptor Agonists as Second-line Therapy in Chronic Immune Thrombocytopenia
Hematology

Choosing Between Thrombopoietin Receptor Agonists as Second-line Therapy in Chronic Immune Thrombocytopenia

expert roundtables
By Adam Cuker, MD, MS; Howard A. Liebman, MD; Terry B. Gernsheimer, MD
Mechanisms Contributing to the Pathophysiology of Immune Thrombocytopenia
Hematology

Mechanisms Contributing to the Pathophysiology of Immune Thrombocytopenia

expert roundtables
By Adam Cuker, MD, MS; Howard A. Liebman, MD; Terry B. Gernsheimer, MD
Identifying Patients With Immune Thrombocytopenia at Risk of Life-threatening Bleeding
Hematology

Identifying Patients With Immune Thrombocytopenia at Risk of Life-threatening Bleeding

expert roundtables
By Adam Cuker, MD, MS; Howard A. Liebman, MD; Terry B. Gernsheimer, MD
Load More